BRPI1012312A2 - peptídeos vangl1 e vacinas incluindo os mesmos - Google Patents
peptídeos vangl1 e vacinas incluindo os mesmosInfo
- Publication number
- BRPI1012312A2 BRPI1012312A2 BRPI1012312A BRPI1012312A BRPI1012312A2 BR PI1012312 A2 BRPI1012312 A2 BR PI1012312A2 BR PI1012312 A BRPI1012312 A BR PI1012312A BR PI1012312 A BRPI1012312 A BR PI1012312A BR PI1012312 A2 BRPI1012312 A2 BR PI1012312A2
- Authority
- BR
- Brazil
- Prior art keywords
- vangl1
- peptides
- same
- vaccines including
- vaccines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
- C12N5/0638—Cytotoxic T lymphocytes [CTL] or lymphokine activated killer cells [LAK]
-
- G01N33/575—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20924209P | 2009-03-04 | 2009-03-04 | |
| PCT/JP2010/001366 WO2010100878A1 (en) | 2009-03-04 | 2010-03-01 | Vangl1 peptides and vaccines including the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1012312A2 true BRPI1012312A2 (pt) | 2017-03-21 |
Family
ID=42709447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1012312A BRPI1012312A2 (pt) | 2009-03-04 | 2010-03-01 | peptídeos vangl1 e vacinas incluindo os mesmos |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20120107333A1 (pt) |
| EP (1) | EP2403943A1 (pt) |
| JP (1) | JP2012519470A (pt) |
| KR (1) | KR20110134446A (pt) |
| CN (1) | CN102439147A (pt) |
| AU (1) | AU2010219951A1 (pt) |
| BR (1) | BRPI1012312A2 (pt) |
| CA (1) | CA2753681A1 (pt) |
| IL (1) | IL214453A0 (pt) |
| MX (1) | MX2011008917A (pt) |
| RU (1) | RU2011140168A (pt) |
| SG (1) | SG174206A1 (pt) |
| TW (1) | TW201043244A (pt) |
| WO (1) | WO2010100878A1 (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201211250A (en) * | 2010-09-07 | 2012-03-16 | Oncotherapy Science Inc | VANGL1 peptides and vaccines including the same |
| IN2014CN03922A (pt) | 2011-10-28 | 2015-09-04 | Oncotherapy Science Inc | |
| JP6159996B2 (ja) | 2012-03-09 | 2017-07-12 | 株式会社富士薬品 | ペプチドを含む医薬組成物 |
| KR102492241B1 (ko) * | 2022-02-25 | 2023-01-30 | 전남대학교산학협력단 | Kitenin의 이량체 형성을 저해하는 펩타이드 및 이의 용도 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2399569A1 (en) * | 2001-09-25 | 2003-03-25 | Yusuke Nakamura | Diagnostic markers and drug targets for treatment of cancer |
| CA2469274A1 (en) * | 2001-12-10 | 2003-06-19 | Kyogo Itoh | Tumor antigens |
| DK2261249T3 (en) * | 2002-09-12 | 2015-02-16 | Oncotherapy Science Inc | KDR peptides and vaccines comprising the same |
| EP2325305B1 (en) * | 2005-02-25 | 2014-02-12 | Oncotherapy Science, Inc. | Peptide vaccines for lung cancers expressing TTK, URLC10 or KOC1 polypeptides |
| HUE027330T2 (en) * | 2005-07-27 | 2016-09-28 | Oncotherapy Science Inc | Colon cancer related gene tom34 |
| PL2091965T3 (pl) * | 2006-10-17 | 2013-10-31 | Oncotherapy Science Inc | Szczepionki peptydowe przeciwko nowotworom z ekspresją polipeptydów MPHOSPH1 lub DEPDC1 |
-
2010
- 2010-03-01 SG SG2011063120A patent/SG174206A1/en unknown
- 2010-03-01 BR BRPI1012312A patent/BRPI1012312A2/pt not_active IP Right Cessation
- 2010-03-01 CA CA2753681A patent/CA2753681A1/en not_active Abandoned
- 2010-03-01 AU AU2010219951A patent/AU2010219951A1/en not_active Abandoned
- 2010-03-01 WO PCT/JP2010/001366 patent/WO2010100878A1/en not_active Ceased
- 2010-03-01 KR KR1020117023280A patent/KR20110134446A/ko not_active Withdrawn
- 2010-03-01 MX MX2011008917A patent/MX2011008917A/es not_active Application Discontinuation
- 2010-03-01 CN CN2010800196356A patent/CN102439147A/zh active Pending
- 2010-03-01 EP EP10748479A patent/EP2403943A1/en not_active Withdrawn
- 2010-03-01 US US13/203,939 patent/US20120107333A1/en not_active Abandoned
- 2010-03-01 JP JP2011537768A patent/JP2012519470A/ja active Pending
- 2010-03-01 RU RU2011140168/10A patent/RU2011140168A/ru not_active Application Discontinuation
- 2010-03-02 TW TW099105932A patent/TW201043244A/zh unknown
-
2011
- 2011-08-04 IL IL214453A patent/IL214453A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL214453A0 (en) | 2011-09-27 |
| JP2012519470A (ja) | 2012-08-30 |
| MX2011008917A (es) | 2011-09-09 |
| KR20110134446A (ko) | 2011-12-14 |
| EP2403943A1 (en) | 2012-01-11 |
| SG174206A1 (en) | 2011-10-28 |
| WO2010100878A1 (en) | 2010-09-10 |
| AU2010219951A1 (en) | 2011-08-25 |
| US20120107333A1 (en) | 2012-05-03 |
| TW201043244A (en) | 2010-12-16 |
| CN102439147A (zh) | 2012-05-02 |
| RU2011140168A (ru) | 2013-04-10 |
| CA2753681A1 (en) | 2010-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2465864T3 (pl) | Szczepionki z peptydem pochodzącym z Eph4 | |
| DK2552434T3 (da) | Peptider og anvendelse deraf | |
| BRPI0914782A2 (pt) | peptídeos de epítopos de cdca1 e vacinas contendo os mesmos | |
| LT3725330T (lt) | Stabilūs polipeptidų preparatai ir jų naudojimas | |
| BRPI1008061A2 (pt) | polipetídeos recombinantes estendidos e composições compreendendo os mesmos | |
| HUE045845T2 (hu) | Módosított relaxin polipeptidek és felhasználásuk | |
| BRPI1008887A2 (pt) | peptídeos de foxm1 e vacinas contendo os mesmo | |
| IL225607A0 (en) | Heteroaryls and uses thereof | |
| IL223667B (en) | S100a4 antibodies and therapeutic uses thereof | |
| BR112012004731A2 (pt) | peptídeos derivados de wnt10 e uso dos mesmos | |
| BR112012003844A2 (pt) | vacinas de pttv e diagnóstico | |
| EP2318438A4 (en) | ANTI-P2X7 PEPTIDES AND EPITOPES | |
| IL229926A (en) | Neil3 peptides and vaccines including the same | |
| IL232461A0 (en) | Melk epitope peptides and vaccines containing the same | |
| IL245924A0 (en) | topk peptides and components comprising them | |
| IL228995A0 (en) | b5sema peptides and components containing them | |
| BRPI1010666A2 (pt) | peptídeos de cdc45l e vacinas incluindo dos mesmos | |
| BRPI1013938A2 (pt) | "peptídeos ttk e vacinas incluindo os mesmos" | |
| BRPI1012312A2 (pt) | peptídeos vangl1 e vacinas incluindo os mesmos | |
| BR112013013158A2 (pt) | peptídeos de tomm34 e vacinas incluindo os mesmos | |
| BRPI0919766A2 (pt) | peptídeo de epítopo de rab6kifl/kif20a e vacinas contendo o mesmo | |
| BRPI0923402A2 (pt) | Peptídeos c10rf59 e vacinas incluindo os mesmos. | |
| BRPI1013384A2 (pt) | peptídeos c6orf167 e vacinas incluindo os mesmos | |
| BRPI0923938A2 (pt) | novos peptideos e uso dos mesmo | |
| ZA201207342B (en) | Ect2 peptides and vaccines including the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |